Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -13.92% vs 24.09% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -24.51% vs 60.36% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -6.10% vs 34.55% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 144.12% vs -20.93% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of China Resources Double-Crane Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -13.51% vs 15.57% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -13.92% vs 24.09% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -6.29% vs 118.70% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -24.51% vs 60.36% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -10.33% vs 122.76% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -6.10% vs 34.55% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -3.49% vs 50.88% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 144.12% vs -20.93% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






